Liraglutide Shows Better Cardiometabolic Benefits Than Lorcaserin in a Novel Free Choice Diet-Induced Obese Rat Model
Metabolism: Clinical and Experimental - Netherlands
doi 10.1016/j.metabol.2019.12.011
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Elsevier BV